Differential prognostic impact of IDH1 and IDH2 mutations in chronic myelomonocytic leukemia

Affiliations

• ¹ Alix School of Medicine, Mayo Clinic, Rochester, MN, USA.
• ² Division of Hematology and Oncology, Moffitt Cancer Center, Tampa, FL, USA.
• ³ Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.
• ⁴ Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
• ⁵ Deparmenent of Malignant Hematology, Moffitt Cancer Center, Tampa, FL, USA.
• ⁶ Deparmenent of Malignant Hematology, Moffitt Cancer Center, Tampa, FL, USA. eric.padron@moffitt.org.
• ⁷ Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA. Patnaik.mrinal@mayo.edu.